Updated OIG Compliance Guidance for Medicare Advantage Stakeholders

The Office of Inspector General (OIG) of the U.S. Department of Health and Human Services has released updated compliance guidance for the Medicare Advantage (MA) sector. This Industry Segment-Specific Compliance Program Guidance (ICPG) revises the nearly 30-year-old directives, laying out new enforcement priorities for stakeholders, including MA organizations, providers, vendors, and associated entities.

The ICPG's introduction aligns with OIG's release of General Compliance Program Guidance in November 2023. This follows their plan to sequentially introduce industry-specific guidelines, with Medicare Advantage following nursing facilities in focus. Although future guidance for other healthcare sectors is planned, their release dates are not yet confirmed.

While non-binding, the ICPG acts as a crucial resource for interpreting OIG’s compliance expectations and enforcement interests. It identifies key risk areas like access to care, marketing practices, risk adjustment compliance, data accuracy, and quality bonus payments. MA organizations (MAOs) are advised to ensure network adequacy and maintain current provider directories to avoid risks such as misrepresentations to the Centers for Medicare & Medicaid Services (CMS) and False Claims Act (FCA) violations.

The guidance highlights OIG's continuing concerns about care denials or delays, especially those tied to prior authorization practices. The use of artificial intelligence in these processes presents emerging risks by potentially overlooking individual clinical needs. MAOs are encouraged to leverage AI responsibly to support medical judgment and to closely monitor denial rates and appeal results.

Marketing practices face scrutiny under this guidance, which warns against compensation structures that may encourage enrollment in unsuitable plans, posing FCA risks. The OIG suggests robust agent and broker training and the implementation of tracking and auditing systems for compensation arrangements.

The guidance also emphasizes the importance of accurate risk adjustment data reporting, warning against the inflation of risk scores through improper chart reviews. MAOs should focus on the precision and completeness of such data to align with CMS requirements, conducting ongoing audits and monitoring.

The document addresses quality bonus payments and Star Ratings, advising MAOs to ensure the reliability of data submitted to CMS. Additionally, with the trend of vertical integration, MAOs are reminded to maintain specific compliance infrastructures to navigate challenges linked to common ownership.

Overall, the ICPG provides comprehensive guidance aiming to aid stakeholders in the Medicare Advantage sector. By aligning compliance strategies with these projections, entities can better navigate regulatory requirements and reduce enforcement exposure. These insights serve as pivotal tools for enhancing compliance frameworks and preparing for regulatory inspections.